Glooko Offers Free Remote Diabetes Care During COVID-19

To cut down on risk of in-person visits, Glooko is providing its remote-care solution that provides live patient-to-clinician connectivity at no charge.

To provide relief during the COVID-19 pandemic, Glooko will provide a no-charge remote-care solution that delivers secure, live patient-to-clinician connectivity.

Glooko provides various digital health and workflow tools to improve diabetes care and communicate and monitor diabetes patients in more than 20 countries.

The company made the move to help reduce in-person contact as part of the global need to curtail the spread of COVID-19. This is especially important for patients with chronic conditions such as diabetes, as they appear to be at a higher risk of contracting the virus.

“For certain appointments, healthcare professionals may determine that the patient and their care team would be best served by a remote review of the patient’s personal diabetes data and a corresponding telehealth consult, reserving in-office visits only for those appointments where a patient’s medical status truly requires in-person treatment,” a statement from the company read.

Interested care providers and patients can learn more about how to access the Glooko remote-care solution at www.glooko.com.

About the Author

David Kopf is the Publisher and Executive Editor of HME Business and DME Pharmacy magazines. Follow him on Twitter at @postacutenews.

Comments

Add your Comment

Your Name:(optional)
Your Email:(optional)
Your Location:(optional)
Comment:
Please type the letters/numbers you see above
Podcast: HME's Emerging COVID-19 Protocols

Subscribe to e-Source

HME Business' free email newsletter keeping you up-to-date and informed.

I agree to this site's Privacy Policy